News
News
- FDA approves Roche's Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer
03/19/2019 / 07:00 - GlobeNewswire - European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease
03/15/2019 / 07:00 - GlobeNewswire - European Commission approves Roche's Hemlibra for people with severe haemophilia A without factor VIII inhibitors
03/14/2019 / 07:00 - GlobeNewswire - Roche's VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq in combination with Abraxane
03/11/2019 / 07:03 - GlobeNewswire - FDA grants Roche's Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer
03/11/2019 / 07:00 - GlobeNewswire - European Commission approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer
03/08/2019 / 07:00 - GlobeNewswire - Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash
03/07/2019 / 17:35 - GlobeNewswire - Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions
03/07/2019 / 14:38 - GlobeNewswire - Roche Annual General Meeting 2019
03/05/2019 / 14:23 - GlobeNewswire - FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers
02/28/2019 / 17:35 - GlobeNewswire